- Home
- MHUA vs OSRH Comparison
MHUA vs OSRH Comparison
Compare MHUA & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- OSRH
- Stock Information
- Founded
- MHUA 1990
- OSRH N/A
- Country
- MHUA China
- OSRH United States
- Employees
- MHUA N/A
- OSRH N/A
- Industry
- MHUA Medical Specialities
- OSRH
- Sector
- MHUA Health Care
- OSRH
- Exchange
- MHUA Nasdaq
- OSRH Nasdaq
- Market Cap
- MHUA 11.8M
- OSRH 11.1M
- IPO Year
- MHUA 2022
- OSRH N/A
- Fundamental
- Price
- MHUA $0.46
- OSRH $0.62
- Analyst Decision
- MHUA
- OSRH
- Analyst Count
- MHUA 0
- OSRH 0
- Target Price
- MHUA N/A
- OSRH N/A
- AVG Volume (30 Days)
- MHUA 132.7K
- OSRH 13.9M
- Earning Date
- MHUA 09-19-2025
- OSRH 08-14-2025
- Dividend Yield
- MHUA N/A
- OSRH N/A
- EPS Growth
- MHUA N/A
- OSRH N/A
- EPS
- MHUA 0.40
- OSRH N/A
- Revenue
- MHUA $96,909,642.00
- OSRH $104,735.00
- Revenue This Year
- MHUA N/A
- OSRH N/A
- Revenue Next Year
- MHUA N/A
- OSRH N/A
- P/E Ratio
- MHUA $1.07
- OSRH N/A
- Revenue Growth
- MHUA N/A
- OSRH N/A
- 52 Week Low
- MHUA $0.25
- OSRH $0.45
- 52 Week High
- MHUA $1.24
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- MHUA 65.24
- OSRH 45.01
- Support Level
- MHUA $0.35
- OSRH $0.57
- Resistance Level
- MHUA $0.46
- OSRH $0.62
- Average True Range (ATR)
- MHUA 0.04
- OSRH 0.10
- MACD
- MHUA 0.00
- OSRH 0.00
- Stochastic Oscillator
- MHUA 73.33
- OSRH 10.81
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.